| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |